ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,987.37
0.30%
US Tech 100
20,205.20
-0.13%
다우존스 지수
44,736.57
0.99%
Bitcoin
94,618.72
1.65%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Bio Path Holdings Inc (BPTH)

  7. Bio Path Holdings Inc (BPTH) 뉴스

BPTH

Bio Path (BPTH)

Bio Path Holdings Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BPTH
일자시간출처헤드라인심볼기업
2024/11/2606:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
2024/11/1521:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
2024/11/1521:00GlobeNewswire Inc.Bio-Path Holdings Reports Third Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
2024/11/1401:15Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BPTHBio Path Holdings Inc
2024/11/0821:00GlobeNewswire Inc.Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024NASDAQ:BPTHBio Path Holdings Inc
2024/11/0706:52Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BPTHBio Path Holdings Inc
2024/10/2905:37Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:BPTHBio Path Holdings Inc
2024/10/2905:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BPTHBio Path Holdings Inc
2024/10/2905:32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BPTHBio Path Holdings Inc
2024/10/2320:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BPTHBio Path Holdings Inc
2024/10/2313:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BPTHBio Path Holdings Inc
2024/10/2304:11Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BPTHBio Path Holdings Inc
2024/10/1906:12Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BPTHBio Path Holdings Inc
2024/10/1805:37Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
2024/10/1106:24GlobeNewswire Inc.Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
2024/10/0909:00GlobeNewswire Inc.Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
2024/10/0820:00GlobeNewswire Inc.Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of ObesityNASDAQ:BPTHBio Path Holdings Inc
2024/09/1620:00GlobeNewswire Inc.Bio-Path Holdings Announces Publication in BiomedicinesNASDAQ:BPTHBio Path Holdings Inc
2024/09/1406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
2024/09/0320:00GlobeNewswire Inc.Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:BPTHBio Path Holdings Inc
2024/08/2205:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
2024/08/2120:00GlobeNewswire Inc.Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid TumorsNASDAQ:BPTHBio Path Holdings Inc
2024/08/1520:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
2024/08/1520:00GlobeNewswire Inc.Bio-Path Holdings Reports Second Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
2024/08/1505:41Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BPTHBio Path Holdings Inc
2024/08/0820:00GlobeNewswire Inc.Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024NASDAQ:BPTHBio Path Holdings Inc
2024/08/0820:00GlobeNewswire Inc.Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024NASDAQ:BPTHBio Path Holdings Inc
2024/08/0207:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPTHBio Path Holdings Inc
2024/08/0207:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPTHBio Path Holdings Inc
2024/08/0207:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPTHBio Path Holdings Inc
 검색 관련기사 보기:NASDAQ:BPTH

최근 히스토리

CCOM
US100
US Tech 100
CCOM
SILVER
SILVER
AMEX
XLV
Health Care Select Sector
USOTC
RHHBY
Roche (QX)
COIN
ETHUSD
Ethereum
NASDAQ
MSFT
Microsoft
USOTC
ADDYY
Adidas (QX)
NASDAQ
TSLA
Tesla
SPI
SP500
S&P 500
FX
USDEUR
US Dollar vs Euro
NASDAQ
NVDA
NVIDIA
CCOM
US500
US 500
AMEX
XLF
Financial Select Sector
NYSE
KO
Coca Cola
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유